BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23866362)

  • 21. Pharmacogenetics of cancer drugs.
    Hertz DL; Rae J
    Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease.
    Roberts RL; Barclay ML
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1546-54. PubMed ID: 22741564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics: transforming clinical medicine.
    Newman WG
    J R Coll Physicians Edinb; 2012; 42(3):244-7. PubMed ID: 22953321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenetic testing: proofs of principle and pharmacoeconomic implications.
    Dervieux T; Meshkin B; Neri B
    Mutat Res; 2005 Jun; 573(1-2):180-94. PubMed ID: 15829247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer drugs find a companion with new diagnostic tests.
    Schubert C
    Nat Med; 2011 Oct; 17(10):1157. PubMed ID: 21988963
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.
    Crea F; Giovannetti E; Zinzani PL; Danesi R
    Crit Rev Oncol Hematol; 2009 Oct; 72(1):21-44. PubMed ID: 19111474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of genomics on the path to personalized medicine.
    Tremblay J; Hamet P
    Metabolism; 2013 Jan; 62 Suppl 1():S2-5. PubMed ID: 23021037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Personalized treatment of cancer: utopia or chance?].
    Thiel E
    Dtsch Med Wochenschr; 2010 Sep; 135(38):1851. PubMed ID: 20842603
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab.
    Longo R; D'Andrea M; Sarmiento R; Gasparini G
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S41-50. PubMed ID: 20374029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenetics of antipsychotics: useful for the clinician?
    Bondy B; Spellmann I
    Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics. Going from genome to pill.
    Service RF
    Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283
    [No Abstract]   [Full Text] [Related]  

  • 32. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenetics and the concept of individualized medicine.
    Shastry BS
    Pharmacogenomics J; 2006; 6(1):16-21. PubMed ID: 16302022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
    Carrillo Norte JA
    Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why, when, and how should pharmacogenetics be applied in clinical studies?: current and future approaches to study designs.
    Stingl Kirchheiner JC; Brockmöller J
    Clin Pharmacol Ther; 2011 Feb; 89(2):198-209. PubMed ID: 21209614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer cell line encyclopedia will help researchers match drugs to patients in clinical trials.
    McBride D
    ONS Connect; 2012 Jun; 27(6):21. PubMed ID: 22774345
    [No Abstract]   [Full Text] [Related]  

  • 37. Genetic tests for predicting the toxicity and efficacy of anticancer chemotherapy.
    Mladosievicova B; Carter A; Kristova V
    Neoplasma; 2007; 54(3):181-8. PubMed ID: 17447847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs.
    Elie V; de Beaumais T; Fakhoury M; Jacqz-Aigrain E
    Pharmacogenomics; 2011 Jun; 12(6):827-43. PubMed ID: 21692614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenetics of the neurodevelopmental impact of anticancer chemotherapy.
    Robaey P; Krajinovic M; Marcoux S; Moghrabi A
    Dev Disabil Res Rev; 2008; 14(3):211-20. PubMed ID: 18924160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpreting disparate responses to cancer therapy: the role of human population genetics.
    Maitland ML; DiRienzo A; Ratain MJ
    J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.